{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:35:34Z","timestamp":1794566134878,"version":"4.9.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>SOX17 has recently emerged as a novel immunohistochemical marker for cancers of endometrial and ovarian origin with improved specificity compared with the widely used Mullerian marker PAX8. However, evaluation of SOX17 in benign and malignant peritoneal mesothelial proliferations remains limited, and these may mimic gynecologic carcinomas, particularly on small biopsies. We evaluated SOX17 and PAX8 expression in 20 benign mesothelial lesions (5 adenomatoid tumors, 5 well-differentiated papillary mesothelial tumors, and 10 peritoneal inclusion cysts) and 16 epithelioid peritoneal mesotheliomas. The 17 female and 3 male patients with benign mesothelial lesions ranged from 20 to 80\u00a0yr (median: 56.5\u00a0yr), while the 9 females and 7 males with mesothelioma ranged from 47 to 85\u00a0yr (median: 57.5\u00a0yr). SOX17 was positive in 5 (25%) benign lesions (2 adenomatoid tumors, 3 peritoneal inclusion cysts) and 2 (13%) mesotheliomas, while PAX8 stained 8 (40%) benign lesions (1 adenomatoid tumor, 1 well-differentiated papillary mesothelial tumor, 6 peritoneal inclusion cysts), and 2 (13%) mesotheliomas. Results for the 2 stains showed incomplete concordance, with agreement in 15 (75%) benign proliferations and 14 (88%) mesotheliomas. Our findings suggest that SOX17 positivity alone is insufficient to confirm a diagnosis of gynecologic carcinoma over a mesothelial proliferation and pathologists should exercise caution when these entities are diagnostic considerations.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001076","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T11:02:48Z","timestamp":1730372568000},"page":"217-221","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["SOX17 Expression in Mesotheliomas and Benign Mesothelial Proliferations: Implications for Differential Diagnosis With Gynecologic Carcinomas"],"prefix":"10.1097","volume":"44","author":[{"given":"Natthawadee","family":"Laokulrath","sequence":"first","affiliation":[{"name":"Department of Pathology, Siraraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin P.","family":"Hung","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn C.","family":"Watkins","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, Davis, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-2437","authenticated-orcid":false,"given":"Kyle M.","family":"Devins","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"R1-20250421","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R2-20250421","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0000000000000883","article-title":"PAX8 expression in breast cancer","volume":"29","author":"Lu","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R3-20250421","doi-asserted-by":"crossref","first-page":"100038","DOI":"10.1016\/j.modpat.2022.100038","article-title":"Identifying SOX17 as a sensitive and specific marker for ovarian and endometrial carcinomas","volume":"36","author":"Shaker","year":"2023","journal-title":"Mod Pathol"},{"key":"R4-20250421","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.modpat.2022.100001","article-title":"SOX17: a highly sensitive and specific immunomarker for ovarian and endometrial carcinomas","volume":"36","author":"Zhang","year":"2023","journal-title":"Mod Pathol"},{"key":"R5-20250421","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gore.2016.04.003","article-title":"A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature","volume":"17","author":"Hancock","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R6-20250421","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40944-022-00692-3","article-title":"Misdiagnosis of peritoneal mesothelioma as ovarian carcinoma in a young female: \u201cwho is gatecrashing your masquerade party?\u201d","volume":"21","author":"Kapoor","year":"2022","journal-title":"Indian J Gynecol Oncol"},{"key":"R7-20250421","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/PGP.0b013e3181e6a3ee","article-title":"Mesothelial neoplasms presenting as, and mimicking, ovarian cancer","volume":"29","author":"Mani","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20250421","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00004347-198909000-00001","article-title":"Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison","volume":"8","author":"Wick","year":"1989","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20250421","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R10-20250421","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R11-20250421","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250421","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.pap.0000201832.15591.1d","article-title":"Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update","volume":"13","author":"Ordonez","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R13-20250421","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anndiagpath.2018.10.012","article-title":"Well-differentiated papillary mesothelioma: a 17-year single institution experience with a series of 75 cases","volume":"38","author":"Sun","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R14-20250421","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.10.036","article-title":"Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study","volume":"72","author":"Xing","year":"2018","journal-title":"Hum Pathol"},{"key":"R15-20250421","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1534-5807(02)00223-X","article-title":"Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families","volume":"3","author":"Schepers","year":"2002","journal-title":"Dev Cell"},{"key":"R16-20250421","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2007.06.093","article-title":"Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos","volume":"360","author":"Sakamoto","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250421","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1101\/gad.2052911","article-title":"Sox17 expression confers self-renewal potential and fetal stem cell characteristics upon adult hematopoietic progenitors","volume":"25","author":"He","year":"2011","journal-title":"Genes Dev"},{"key":"R18-20250421","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncy.22708","article-title":"SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens","volume":"131","author":"Satturwar","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"R19-20250421","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00000478-198908000-00004","article-title":"Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison","volume":"13","author":"Bollinger","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R20-20250421","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R21-20250421","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/PAS.0000000000001924","article-title":"Localized malignant peritoneal mesothelioma (LMPeM) in women: a clinicopathologic study of 18 cases","volume":"46","author":"Malpica","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R22-20250421","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemiol"},{"key":"R23-20250421","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAS.0000000000001545","article-title":"Malignant mesothelioma of the peritoneum in women: a clinicopathologic study of 164 cases","volume":"45","author":"Malpica","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R24-20250421","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.path.2022.02.005","article-title":"Peritoneal pathology review: Mullerian, mucinous and mesothelial lesions","volume":"15","author":"Kiyokawa","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"R25-20250421","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.path.2019.02.006","article-title":"Low-grade serous neoplasia of the female genital tract","volume":"12","author":"Folkins","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"R26-20250421","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R27-20250421","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PGP.0000000000000685","article-title":"Adenomatoid tumor of the uterus: a report of 6 unusual cases with prominent cysts including 4 with diffuse myometrial involvement, 4 with uterine serosal involvement, and 2 presenting in curettage specimens","volume":"40","author":"Lerias","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20250421","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/PAS.0000000000002249","article-title":"Large and extensive multilocular peritoneal inclusion cysts lack genomic alterations and follow an indolent clinical course despite rare recurrences","volume":"48","author":"Devins","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R29-20250421","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/modpathol.2012.200","article-title":"Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas","volume":"26","author":"Ordonez","year":"2013","journal-title":"Mod Pathol"},{"key":"R30-20250421","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"R31-20250421","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R32-20250421","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5603\/FHC.a2020.0022","article-title":"Wilms\u2019 tumor 1 antigen immunoreactivity in epithelial ovarian cancer - diagnostic and prognostic value","volume":"58","author":"Zarychta","year":"2020","journal-title":"Folia Histochem Cytobiol"},{"key":"R33-20250421","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Comin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R34-20250421","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.2008.108","article-title":"Immunophenotyping of serous carcinoma of the female genital tract","volume":"21","author":"Nofech-Mozes","year":"2008","journal-title":"Mod Pathol"},{"key":"R35-20250421","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ordonez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R36-20250421","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1309\/8FCHQ3VPBWM7B5X9","article-title":"Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful","volume":"125","author":"Barnetson","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R37-20250421","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"R38-20250421","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1309\/AJCPHSUJ15NEYMIP","article-title":"A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases","volume":"130","author":"Takeshima","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R39-20250421","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/modpathol.2013.34","article-title":"Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma","volume":"26","author":"Ordonez","year":"2013","journal-title":"Mod Pathol"},{"key":"R40-20250421","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PGP.0000000000000877","article-title":"BAP1 and Claudin-4, but not MTAP, reliably distinguish borderline and low-grade serous ovarian tumors from peritoneal mesothelioma","volume":"42","author":"Devins","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20250421","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","article-title":"Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses","volume":"69","author":"Kawai","year":"2016","journal-title":"J Clin Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:00:28Z","timestamp":1745251228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001076","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}